17 min listen
Using AI Created Digital Twins to Accelerate Clinical Trials
FromThe Bio Report
ratings:
Length:
26 minutes
Released:
Dec 3, 2020
Format:
Podcast episode
Description
One of the challenges of conducting clinical trials is finding enough patient to include in a control arm of a study. This can slow the pace of drug development and increase its costs. Unlearn.AI is seeking to change that by using its artificial intelligence platform to create digital twins of trial participants that can serve as control arms in studies. We spoke to Charles Fisher, founder and CEO of Unlearn, about the concept of digital twins, the potential to accelerate clinical trials with their use, and why the company is focusing on the area of complex neurologic diseases.
Released:
Dec 3, 2020
Format:
Podcast episode
Titles in the series (100)
Will Funding for Obama’s Precision Medicine Initiative Match Its Ambition: President Obama unveiled the details of his $215 million precision medicine initiative, the centerpiece of which is a 1 million person study that seeks to correlate genetic data, with health records, lifestyle information, and more to better understa... by The Bio Report